Columbia University

Technology Ventures

Featured Funding Opportunities

In support of its mission to facilitate the transfer of inventions from academic research labs to the market, CTV publicizes funding opportunities that may be relevant to Columbia inventors as they conduct research and develop new technologies. For additional lists of funding opportunities, refer to these resources:

For further assistance with grant applications, see CTV's collection of IP and Entrepreneurship Language for Grant Applications.

Upcoming Opportunities

right
Deadline: 
Monday, September 27, 2021 - 5:00pm

Applications are now available for New York State’s new $40 million Biodefense Commercialization Fund that will provide grants of as much as $4 million to startups and academic research projects to help accelerate the development and commercialization of life science research that addresses serious infectious disease threats, including COVID-19 and its variants.

Past Funding Opportunities

right
Deadline: 
Wednesday, June 30, 2021 - 10:00am

aMoon Velocity is aMoon’s early-stage investment fund. Our investments target disruptive, cutting-edge technologies and range from sponsored research at top academic and clinical institutions, to venture formation through seed investments. We don’t define ourselves by vertical, need, or even geographical boundaries but by our passion for partnering with entrepreneurs and scientists developing new solutions to major healthcare challenges.

right
Deadline: 
Friday, May 28, 2021 - 5:00pm
Innovosource is partnering with Philips Image Guided Therapy Devices to identify partnership opportunities related to these specific technical challenges:
right
Deadline: 
Friday, April 9, 2021 - 5:00pm

 Bristol Myers Squibb II-ON seeks proposals on topics designed to address questions developed by its Tumor Microenvironment Modulation Thematic Research Center. 

KEY QUESTIONS FOR RFP CHALLENGE:

right
Deadline: 
Monday, June 21, 2021 - 5:00pm

Pfizer’s Centers for Therapeutic Innovation (CTI) requests proposals for novel therapeutic targets with application across Pfizer's core therapeutic areas:

right
Deadline: 
Thursday, April 15, 2021 - 5:00pm

The RTW Charitable Foundation’s mission is to improve opportunities for all people to live healthier, longer lives by identifying unmet needs and impacting research and patients directly.  

right
Deadline: 
Thursday, February 25, 2021 - 5:00pm

CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations.

The 2021 Research Acceleration Initiative will focus on research projects that span a CSL Therapeutic Area and a Focus Area, and that are amenable to or include a Modality listed below:

Therapeutic Area (emphasis on rare disease):

  • Immunology
  • Hematology
  • Respiratory
  • Cardiovascular/Metabolic
  • Transplant

Focus Areas:

right
Deadline: 
Tuesday, February 23, 2021 - 12:00am

Columbia University, New York University, and Takeda Pharmaceuticals have formed a collaborative research alliance to initiate and advance gastroenterology (GI) research programs with high potential to impact the development of new therapeutics for patients with GI disorders. This cycle of the Alliance has a particular thematic focus on GI Inflammation and neuroinflammation; motility and modulating enteric nervous system biology; and liver.

right
Deadline: 
Monday, February 15, 2021 - 11:00pm

 

 

Are you a Columbia-based team developing innovative advance materials technologies with the potential to transform industries? Apply to Corning | Columbia Advanced Materials Prize, a joint effort between Corning IncorporatedColumbia Material Research Science and Engineering Center (MRSEC), and Columbia Lab-to-Market Accelerator Network (L2M)

Pages